55625-40-6

Basic information

• Product Name: 2-METHYL-QUINOLINE-4-CARBOXYLIC ACID METHYL ESTER
• Synonyms: AKOS B001515;2-METHYL-QUINOLINE-4-CARBOXYLIC ACID METHYL ESTER;ART-CHEM-BB B001515;VITAS-BB TBB002234
• CAS NO: 55625-40-6
• Molecular Formula: C₁₂H₁₁NO₂
• Molecular Weight: 201.22
• Mol File: 55625-40-6.mol
• Article Data: 3

Chemical Properties

• Melting Point: 60-61 °C
• Boiling Point: 314.8±22.0 °C(Predicted)
• Appearance: /
• Density: 1.177±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 3.63±0.50(Predicted)
• CAS DataBase Reference: 2-METHYL-QUINOLINE-4-CARBOXYLIC ACID METHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 2-METHYL-QUINOLINE-4-CARBOXYLIC ACID METHYL ESTER(55625-40-6)
• EPA Substance Registry System: 2-METHYL-QUINOLINE-4-CARBOXYLIC ACID METHYL ESTER(55625-40-6)

Safety Data

• Hazardous Substances Data: 55625-40-6(Hazardous Substances Data)

Usage

General Description

2-Methyl-quinoline-4-carboxylic acid methyl ester, also known as 2-Methyl-4-carboxyquinoline methyl ester, is a chemical compound with the molecular formula C12H11NO2. It is a methyl ester derivative of 2-methyl-4-carboxyquinoline, a heterocyclic aromatic compound. This chemical is used as a building block in the synthesis of various pharmaceutical compounds and can be used as a starting material for the preparation of quinoline-based drugs and other bioactive molecules. Its properties and potential applications make it an important compound in the pharmaceutical and chemical industries.

Upstream product

• 186581-53-3 diazomethane 
• 634-38-8 2-methylquinoline-4-carboxylic acid 
• 65417-20-1 methyl 2-methylquinoline-4-carboxylate 1-oxide 
• 91-56-5 indole-2,3-dione 
• 67-56-1 methanol 

Downstream Products

• 4939-28-0 4-(hydroxymethyl)-2-methylquinoline 
• 15821-13-3 2-methylquinoline-4-carboxamide 
• 29620-66-4 2-methylquinoline-4-carboxylic hydrazide 
• 6760-22-1 2-methylquinoline-4-carboxaldehyde 

Relevant articles and documents

Quinoline substituted chalcone compound as well as preparation method and application thereof

The invention discloses a novel quinoline substituted chalcone compound as well as pharmaceutically acceptable salts and a preparation method thereof. The invention further discloses a pharmaceuticalcomposition which comprises a therapeutically effective amount of the novel quinoline substituted chalcone compound and/or the pharmaceutically acceptable salts and a pharmaceutically acceptable carrier. The invention further discloses a tubulin inhibitor which comprises the novel quinoline substituted chalcone compound and/or the pharmaceutically acceptable salts. The invention further disclosesapplication of the novel quinoline substituted chalcone compound and/or the pharmaceutically acceptable salts in preparing drugs for treating but not limited to colon cancer, leukemia, liver cancer, breast cancer and other diseases. The compound in the application shows excellent anti-tumor activity, and has more stable metabolic properties and better druggability prospect.

Studies on the N-oxides of π-deficient N-heteroaromatics. XXIV. A novel synthesis of substituted indoles by photochemical ring contraction of 3,1-benzoxazepines

-